\-\ Texto\\:\\ \ \(0\)\
\-\ 77\\ y\\/o\\ with\\ abdominal\\ pain\ \(1\)\
\-\ patient\\ may\\ have\\ biopsy\\ to\\ confirm\\ and\\ then\\ may\\ have\\ to\\ reduce\\ amiodorone\\ or\\ change\\ drug\\ regimen\\.\ \(0\)\
\-\ hyperdense\\ liver\ \(1\)\
\-\ increased\\ liver\\ attenuation\\ \\(amiodarone\\)\ \(0\)\
\-\ iron\\ deposition\\ \\(primary\\ or\\ secondary\\ hemochromatosis\\)\ \(0\)\
\-\ cisplatin\\ therapy\ \(0\)\
\-\ colloidal\\ gold\\ therapy\ \(0\)\
\-\ wilson\\ disease\ \(1\)\
\-\ thorotrast\ \(0\)\
\-\ amiodorone\\ therapy\ \(0\)\
\-\ 77\\ y\\.o\\.\\ woman\\ with\\ with\\ abdominal\\ pain\\ and\\ an\\ incidental\\ finding\\ on\\ chest\\ ct\\.\\ \\ has\\ history\\ of\\ amiodarone\\ treatment\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ amiodorone\\:\\ 0\\.2518719549704714\ \(0\)\
\-\ amiodarone\\:\\ 0\\.18608380945635578\ \(0\)\
\-\ 77\\:\\ 0\\.14870287175206495\ \(0\)\
\-\ colloidal\\:\\ 0\\.1160338749058079\ \(0\)\
\-\ thorotrast\\:\\ 0\\.1160338749058079\ \(0\)\
\-\ cisplatin\\:\\ 0\\.1003394136391206\ \(0\)\
\-\ therapy\\:\\ 0\\.09791317698174055\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.08464495237243334\ \(0\)\
\-\ liver\\:\\ 0\\.08417775745236353\ \(0\)\
\-\ wilson\\:\\ 0\\.08177822815154547\ \(0\)\
\-\ gold\\:\\ 0\\.08053520848026503\ \(0\)\
\-\ iron\\:\\ 0\\.07687901742116217\ \(0\)\
\-\ regimen\\:\\ 0\\.07642546458809674\ \(0\)\
\-\ reduce\\:\\ 0\\.06895049110574605\ \(0\)\
\-\ deposition\\:\\ 0\\.0681781022304564\ \(0\)\
\-\ drug\\:\\ 0\\.06263859464461691\ \(0\)\
\-\ confirm\\:\\ 0\\.06213729007588449\ \(0\)\
\-\ hyperdense\\:\\ 0\\.06103176630994992\ \(0\)\
\-\ abdominal\\:\\ 0\\.06102626394634615\ \(0\)\
\-\ may\\:\\ 0\\.053552239111374966\ \(0\)\
\-\ have\\:\\ 0\\.052869659381859765\ \(0\)\
\-\ attenuation\\:\\ 0\\.04908030100608626\ \(0\)\
\-\ change\\:\\ 0\\.04758173557822633\ \(0\)\
\-\ incidental\\:\\ 0\\.04622555139971823\ \(0\)\
\-\ then\\:\\ 0\\.04344238397745842\ \(0\)\
\-\ biopsy\\:\\ 0\\.04330990345195372\ \(0\)\
\-\ finding\\:\\ 0\\.03934373578626402\ \(0\)\
\-\ primary\\:\\ 0\\.036162632327081376\ \(0\)\
\-\ y\\.o\\:\\ 0\\.03523399189409571\ \(0\)\
\-\ secondary\\:\\ 0\\.03412899952155439\ \(0\)\
\-\ y\\/o\\:\\ 0\\.03380898614028058\ \(0\)\
\-\ increased\\:\\ 0\\.02986406831142365\ \(0\)\
\-\ pain\\:\\ 0\\.029817376215163848\ \(0\)\
\-\ chest\\:\\ 0\\.02921041428653598\ \(0\)\
\-\ or\\:\\ 0\\.028614935684677358\ \(0\)\
\-\ woman\\:\\ 0\\.028198613535555802\ \(0\)\
\-\ treatment\\:\\ 0\\.0247088137085841\ \(0\)\
\-\ has\\:\\ 0\\.022924285292775397\ \(0\)\
\-\ \\(\\:\\ 0\\.0206389064641103\ \(0\)\
\-\ \\)\\:\\ 0\\.020386791203237286\ \(0\)\
\-\ disease\\:\\ 0\\.01995339344593863\ \(0\)\
\-\ ct\\:\\ 0\\.017075766477029183\ \(0\)\
\-\ an\\:\\ 0\\.016880926632638998\ \(0\)\
\-\ history\\:\\ 0\\.016860207681529762\ \(0\)\
\-\ patient\\:\\ 0\\.012237027584519828\ \(0\)\
\-\ to\\:\\ 0\\.012201945955513892\ \(0\)\
\-\ on\\:\\ 0\\.010341300176648973\ \(0\)\
\-\ and\\:\\ 0\\.005143114449491956\ \(0\)\
\-\ with\\:\\ 0\\.005014464689566703\ \(0\)\
\-\ of\\:\\ 0\\.0016643400113998347\ \(0\)\
\-\ \\.\\:\\ 0\\.001521408689886269\ \(0\)\
